I think Fulgent Genetics is extremely cheap and institutional investors are just barely starting to take notice. The near term catalysts for massive upside are already in play and not priced into the stock.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.